Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation

Fluids and Barriers of the CNS

Volumn 9, Issue 1, 2012, Pages

  Schellenberg, Angela E ^a   Buist, Richard ^a   Del Bigio, Marc R ^a   Toft Hansen, Henrik ^b   Khorooshi, Reza ^c   Owens, Trevor ^c,d   Peeling, James ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Central nervous system; Chemokine; Inflammation; Magnetic resonance imaging; Multiple sclerosis

Indexed keywords

DEXTRAN; FLUORESCENT DEXTRAN; GADOLINIUM PENTETATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DRUG PENETRATION; ENCEPHALITIS; ENDOTHELIUM; FEMALE; GLIA CELL; HISTOPATHOLOGY; MALE; MOLECULAR SIZE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TIGHT JUNCTION;

EID: 84865344876     PISSN: None     EISSN: 20458118     Source Type: Journal    
DOI: 10.1186/2045-8118-9-10     Document Type: Article

References (31)

1. Kermode AG, Thompson AJ, Tofts P, MacManus DG, Kendall BE, Kingsley DP, Moseley IF, Rudge P, McDonald WI. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications. Brain 1990, 113:1477-1489.
2. Kermode AG, Tofts PS, Thompson AJ, MacManus DG, Rudge P, Kendall BE, Kingsley DP, Moseley IF. du-Boulay EP, McDonald WI: Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement. Neurology 1990, 40:229-235. 10.1212/WNL.40.2.229, 2300240.
3. Leibowitz S, Kennedy L. Cerebral vascular permeability and cellular infiltration in experimental allergic encephalomyelitis. Immunology 1972, 22:859-869. 1407847, 5021707.
4. Juhler M, Barry DI, Offner H, Konat G, Klinken L, Paulson OB. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat. Brain Res 1984, 302:347-355. 10.1016/0006-8993(84)90249-X, 6610460.
5. Kitz K, Lassmann H, Karcher D, Lowenthal A. Blood-brain barrier in chronic relapsing experimental allergic encephalomyelitis: a correlative study between cerebrospinal fluid protein concentrations and tracer leakage in the central nervous system. Acta Neuropathol 1984, 63:41-50. 10.1007/BF00688469, 6730912.
6. Hawkins CP, Munro PM, MacKenzie F, Kesselring J, Tofts PS. du-Boulay EP, Landon DN, McDonald WI: Duration and selectivity of blood-brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium-DTPA and protein markers. Brain 1990, 113:365-378. 10.1093/brain/113.2.365, 2328409.
7. Hawkins CP, MacKenzie F, Tofts P, du Boulay BE, McDonald WI. Patterns of blood-brain barrier breakdown in inflammatory demyelination. Brain 1991, 114:801-810. 10.1093/brain/114.2.801, 2043950.
8. Morrissey SP, Stodal H, Zettl U, Simonis C, Jung S, Kiefer R, Lassmann H, Hartung HP, Haase A, Toyka KV. In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis. Quantification of inflammation and oedema. Brain 1996, 119:239-248.
9. Floris S, Blezer EL, Schreibelt G, Dopp E, Van Der Pol SM, Schadee-Eestermans IL, Nicolay K, Dijkstra CD, de Vries HE. Blood-brain barrier permeability and monocyte infiltration in experimental allergic encephalomyelitis. Brain 2004, 127:616-627.
10. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol 1999, 72:7-29.
11. Mahad DJ, Ransohoff RM. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin Immunol 2003, 15:23-32. 10.1016/S1044-5323(02)00125-2, 12495638.
12. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF. MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 1998, 86:20-29. 10.1016/S0165-5728(98)00002-2, 9655469.
13. Simpson JE, Newcombe J, Cuzner ML, Woodroofe MN. Expression of monocyte chemoattractant protein-1 and other beta-chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. J Neuroimmunol 1998, 84:238-249. 10.1016/S0165-5728(97)00208-7, 9628469.
14. Van Der Voorn P, Tekstra J, Beelen RH, Tensen CP, Van Der Valk P, De Groot CJ. Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am J Pathol 1999, 154:45-51. 10.1016/S0002-9440(10)65249-2, 1853444, 9916917.
15. Ransohoff RM, Hamilton TA, Tani M, Stoler MH, Shick HE, Major JA, Estes ML, Thomas DM, Tuohy VK. Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J 1993, 7:592-600.
16. Babcock AA, Kuziel WA, Rivest S, Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 2003, 23:7922-7930.
17. Fuentes ME, Durham SK, Swerdel MR, Lewin AC, Barton DS, Megill JR, Bravo R, Lira SA. Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol 1995, 155:5769-5776.
18. Toft-Hansen H, Buist R, Sun XJ, Schellenberg A, Peeling J, Owens T. Metalloproteinases control brain inflammation induced by pertussis toxin in mice overexpressing the chemokine CCL2 in the central nervous system. J Immunol 2006, 177:7242-7249.
19. Owens T, Bechmann I, Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 2008, 67:1113-1121. 10.1097/NEN.0b013e31818f9ca8, 19018243.
20. Bergman RK, Munoz JJ, Portis JL. Vascular permeability changes in the central nervous system of rats with hyperacute experimental allergic encephalomyelitis induced with the aid of a substance from Bordetella pertussis. Infect Immun 1978, 21:627-637. 422039, 211087.
21. Wolburg H, Wolburg-Buchholz K, Engelhardt B. Diapedesis of mononuclear cells across cerebral venules during experimental autoimmune encephalomyelitis leaves tight junctions intact. Acta Neuropathol 2005, 109:181-190. 10.1007/s00401-004-0928-x, 15549331.
22. Song L, Pachter JS. Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvasc Res 2004, 67:78-89. 10.1016/j.mvr.2003.07.001, 14709405.
23. Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, Andjelkovic AV. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. J Cereb Blood Flow Metab 2005, 25:593-606. 10.1038/sj.jcbfm.9600055, 15689955.
24. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV. Protein kinase Calpha-RhoA cross-talk in CCL2-induced alterations in brain endothelial permeability. J Biol Chem 2006, 281:8379-8388. 10.1074/jbc.M513122200, 16439355.
25. Bruckener KE, el Baya A, Galla HJ, Schmidt MA. Permeabilization in a cerebral endothelial barrier model by pertussis toxin involves the PKC effector pathway and is abolished by elevated levels of cAMP. J Cell Sci 2003, 116:1837-1846. 10.1242/jcs.00378, 12665564.
26. Linthicum DS, Munoz JJ, Blaskett A. Acute experimental autoimmune encephalomyelitis in mice. I. Adjuvant action of Bordetella pertussis is due to vasoactive amine sensitization and increased vascular permeability of the central nervous system. Cell Immunol 1982, 73:299-310. 10.1016/0008-8749(82)90457-9, 6891621.
27. Yong T, Meininger GA, Linthicum DS. Enhancement of histamine-induced vascular leakage by pertussis toxin in SJL/J mice but not BALB/c mice. J Neuroimmunol 1993, 45:47-52. 10.1016/0165-5728(93)90162-R, 8331165.
28. Tonra JR, Reiseter BS, Kolbeck R, Nagashima K, Robertson R, Keyt B, Lindsay RM. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J Comp Neurol 2001, 430:131-144. 10.1002/1096-9861(20010129)430:1<131::AID-CNE1019>3.0.CO;2-K, 11135250.
29. Nishino A, Suzuki M, Ohtani H, Motohashi O, Umezawa K, Nagura H, Yoshimoto T. Thrombin may contribute to the pathophysiology of central nervous system injury. J Neurotrauma 1993, 10:167-179. 10.1089/neu.1993.10.167, 7692071.
30. Lee KR, Kawai N, Kim S, Sagher O, Hoff JT. Mechanisms of edema formation after intracerebral hemorrhage: effects of thrombin on cerebral blood flow, blood-brain barrier permeability, and cell survival in a rat model. J Neurosurg 1997, 86:272-278. 10.3171/jns.1997.86.2.0272, 9010429.
31. Xi G, Keep RF, Hoff JT. Pathophysiology of brain edema formation. Neurosurg Clin N Am 2002, 13:371-383. 10.1016/S1042-3680(02)00007-4, 12486926.